상세 보기
초록
Objective: We examined the putative association between the levels of hematocrit and improvement of cognitive function as well as quality of life in patients with end-stage renal disease (ESRD). Methods: Fifty-six ESRD patients were divided into two groups according to their hematocrit levels: Group A consisted of 28 patients with hematocrit levels lower than the median (27.2 g%), while Group B, the remaining 28 patients, with higher than the median level. Neurocognitive function and the quality of life in these two groups were compared. Results: Although patients with higher hematocrit levels scored better in the neurocognitive function tests such as the forward digit-span (P=.034) and digit-symbol (P=.023), their quality of life evaluated by three scales (Karnofsky Scale, Index of Well-Being, and SF-36) was not any better than those with lower hematocrit group. Conclusions: The present study indicated that in chronic hemodialysis patients, the higher hematocrit levels improve neurocognitive function but not the quality of life. (C) 2004 Elsevier Inc. All rights reserved.
키워드
- 제목
- Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients
- 저자
- Lee, SY; Lee, HJ; Kim, YK; Kim, SH; Kim, L; Lee, MS; Joe, SH; Jung, IK; Suh, KY; Kim, HK
- 발행일
- 2004-07
- 유형
- Article
- 권
- 57
- 호
- 1
- 페이지
- 5 ~ 10
- 언어
- ENG
- 출판사
- Elsevier BV
- 발행국가
- 영국
- 분량
- 6 페이지
- ISSN
- E 1879-1360
P 0022-3999